Haystack iS (iatricSystems) vs Imprivata Patient Privacy Intelligence
Two philosophies of privacy monitoring. Haystack detects anomalies and lets you tune them: its Solomon engine learns organisation specific baselines and privacy teams adjust the event weights themselves, on the deepest integration estate in the category, more than 180 named systems plus an open audit file path, which matters because monitoring only works if it sees every system where PHI lives. Imprivata explains rather than detects: its Explanation Based Auditing method, the only one here with peer reviewed academic validation, tries first to tie each access to a legitimate clinical reason and flags only the residue it cannot account for, which structurally avoids flagging a clinician for being statistically unusual and earns the best governance grade among the workforce surveillance vendors. The catch on Imprivata's side is continuity: much of that evidence and its data stays inside deployment model predate the FairWarning and Maize merger. If your failure mode is seeing every system across a fragmented estate, start with Haystack. If your failure mode is minimising false accusations with a method that explains, start with Imprivata, and confirm what survived the merger.
- The deepest integration estate in the category, graded A: named support across Epic, Cerner, MEDITECH, Allscripts, athenahealth, and Quadramed among more than 180 vendors, plus an open audit file import specification that works with virtually any system generating an audit file.
- Privacy monitoring only works if it sees every system where PHI is accessible, and 35 years of integration experience across a reported 1,300 plus hospitals is the moat that makes that coverage real, with a stated commitment to build the connection if a system is not yet supported.
- The customer controls the risk model: privacy teams adjust event weights themselves so scoring aligns with their own policy rather than a vendor fixed model, and the strongest published PHI stewardship posture in the lane, graded A, including the diligence questions buyers should ask of any AI vendor.
- The only peer reviewed academic validation of its core method in the category, graded A on evidence: the Explanation Based Auditing research was published and evaluated against a real University of Michigan Health System log, reporting explanations for over 94 percent of accesses, plus Best in KLAS in 2021.
- A method that structurally avoids flagging people for being unusual, graded A on governance: it explains each access against a legitimate clinical reason and surfaces only the unexplained residue, a claim about evidence rather than about the person, which is the best governance posture among the workforce surveillance vendors indexed.
- Data does not leave the organisation, graded A on deployment and PHI: the system runs in a virtual machine inside the customer environment, the strongest residency position available for a platform this PHI dense.
Side-by-Side
| Axis | H Haystack iS (iatricSystems) |
I Imprivata Patient Privacy Intelligence |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Both are patient privacy monitoring platforms, and the split is integration reach against method and evidence. Haystack grades A on interoperability and PHI stewardship, with the deepest connection estate and the most complete published disclosure posture; Imprivata grades A on AI centrality, model transparency, evidence, governance, autonomy, and deployment for the Explanation Based Auditing method, but B on interoperability because no named integration list was located for the merged product where Haystack enumerates more than 180. Two caveats matter. Imprivata's evidence and its in customer deployment model largely predate the merger of FairWarning and Maize into Patient Privacy Intelligence, so buyers should confirm which capabilities carried over. Haystack's AVA assistant contacts a flagged employee directly with a questionnaire before a human auditor has necessarily reviewed the case, which is efficient and also an automated system initiating what an employee will read as an accusation, graded B on autonomy. Neither publishes a security attestation or pricing.